AJANTPHARM

AJANTA PHARMA

Mid Cap BSE: 532331 NSE: AJANTPHARM
₹1235.00
11.75 (0.96%)
As on 26 November, 2022 | 14:35

Ajanta Pharma Share Price

Ajanta Pharma Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in AJANTA PHARMA

Start SIP

Ajanta Pharma Share Returns

  • Over 1 Month -2.12%
  • Over 3 Month -8.23%
  • Over 6 Month 8.9%
  • Over 1 Year -11.28%

Ajanta Pharma Key Statistics

P/E Ratio 23.5
PEG Ratio -5.3
Market Cap Cr 15,824
Price to Book Ratio 4.9
EPS 56.2
Dividend 0.6
Relative Strength Index 42.45
Money Flow Index 34.63
MACD Signal -8.59
Average True Range 39.33

Ajanta Pharma Investment Rating

  • Master Rating:
  • Ajanta Pharma has an operating revenue of Rs. 3,597.23 Cr. on a trailing 12-month basis. An annual revenue growth of 19% is outstanding, Pre-tax margin of 27% is great, ROE of 21% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and close to its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 62 which is a FAIR score but needs to improve its earnings, a RS Rating of 33 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C+ which is evident from recent supply seen, Group Rank of 104 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of D is close to being the worst. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Ajanta Pharma Financials
IndicatorSep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021
Oper Rev Qtr Cr 837850766809824743748
Operating Expenses Qtr Cr 677664578571591510501
Operating Profit Qtr Cr 161186187238233233247
Depreciation Qtr Cr 32313031303029
Interest Qtr Cr 1171012
Tax Qtr Cr 39404340584062
Net Profit Qtr Cr 167150135195197193155

Ajanta Pharma Technicals

EMA & SMA

Current Price
1235.
11.75 (0.96%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 1255.09
  • 50 Day
  • 1268.66
  • 100 Day
  • 1267.02
  • 200 Day
  • 1242.46
  • 20 Day
  • 1268.91
  • 50 Day
  • 1269.42
  • 100 Day
  • 1278.52
  • 200 Day
  • 1241.66

Ajanta Pharma Resistance and Support

PIVOT
₹1223.97
Resistance
First Resistance 1232.94
Second Resistance 1242.62
Third Resistance 1251.59
RSI 42.45
MFI 34.64
MACD Single Line -8.59
MACD -13.58
Support
First Resistance 1214.29
Second Resistance 1205.32
Third Resistance 1195.64

Ajanta Pharma Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 21,348 1,149,163 53.83
Week 64,072 4,653,564 72.63
1 Month 92,517 3,845,924 41.57
6 Month 101,102 6,446,289 63.76

Ajanta Pharma Result Highlights

Ajanta Pharma Synopsis

NSE-Medical-Generic Drugs

Ajanta Pharma Lt is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 3140.64 Cr. and Equity Capital is Rs. 17.17 Cr. for the Year ended 31/03/2022. Ajanta Pharma Ltd. is a Public Limited Listed company incorporated on 31/12/1979 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH1979PLC022059 and registration number is 022059.
Market Cap 15,787
Sales 3,262
Shares in Float 3.84
No of funds 185
Yield 0.57
Book Value 4.98
U/D Vol ratio 1.1
LTDebt / Equity
Alpha -0.05
Beta 0.4

Ajanta Pharma

Owner NameSep-22Jun-22Mar-22Dec-21
Promoters 70.48%70.48%70.48%
Mutual Funds 11.14%10.88%10.5%
Insurance Companies 1.01%1.04%1.11%
Foreign Portfolio Investors 8.23%8.3%8.64%
Financial Institutions/ Banks
Individual Investors 7.31%7.46%7.33%
Others 1.83%1.84%1.94%

Ajanta Pharma Management

Name Designation
Mr. Mannalal B Agrawal Chairman
Mr. Madhusudan B Agrawal Vice Chairman
Mr. Yogesh M Agrawal Managing Director
Mr. Rajesh M Agrawal Joint Managing Director
Dr. Anjana Grewal Independent Director
Mr. Chandrakant M Khetan Independent Director
Mr. K H Viswanathan Independent Director
Mr. Prabhakar R Dalal Independent Director

Ajanta Pharma Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Ajanta Pharma Corporate Action

Date Purpose Remarks
2022-11-03 Quarterly Results & Interim Dividend
2022-07-28 Quarterly Results
2022-05-10 Audited Results & Bonus issue
2022-01-31 Quarterly Results
2021-12-28 Buy Back of Shares
Date Purpose Remarks
2022-11-14 INTERIM Rs.7.00 per share(350%)Interim Dividend
2021-11-10 INTERIM Rs.9.50 per share(475%)Interim Dividend
Date Purpose Remarks
2022-06-23 Bonus Rs.0.00 issue in the ratio of 1:2 of Rs. 2/-.

Ajanta Pharma MF Shareholding

Name Amount(cr)
HDFC Balanced Advantage Fund Growth 49709
Mirae Asset Large Cap Fund Regular Growth 34407
UTI Flexi Cap Fund Regular Plan Growth 26133
Mirae Asset Emerging Bluechip Fund Growth 23691
Nippon India Small Cap Fund - Growth 22844

Ajanta Pharma FAQs

What is Share Price of Ajanta Pharma ?

Ajanta Pharma share price is ₹1235 As on 26 November, 2022 | 14:21

What is the Market Cap of Ajanta Pharma ?

The Market Cap of Ajanta Pharma is ₹15823.5 Cr As on 26 November, 2022 | 14:21

What is the P/E ratio of Ajanta Pharma ?

The P/E ratio of Ajanta Pharma is 23.5 As on 26 November, 2022 | 14:21

What is the PB ratio of Ajanta Pharma ?

The PB ratio of Ajanta Pharma is 4.9 As on 26 November, 2022 | 14:21

Q2FY23